Skip to main content

Animations

Beakers with MJFF logo.

The Bachmann-Strauss Dystonia & Parkinson Foundation Timeline

 
1979
Bonnie Strauss diagnosed with dystonia
Head shot of board member Bonnie Strauss.

Bonnie Strauss begins experiencing neck spasms that force her to seek medical attention. Bonnie visits all types of doctors, from psychiatrists to chiropractors, seeking answers. In 1984, five years after onset of symptoms, Bonnie is connected with a neurologist in New York City, who properly diagnoses her with spasmodic torticollis, a form of dystonia characterized by involuntary contractions of the muscles in the neck. Bonnie comes to strongly believe there is a link between dystonia and Parkinson's, having seen her mother and grandmother both live with Parkinson's disease.

Advocacy / Awareness icon
Advocacy / Awareness
1993
Inaugural Dystonia Golf Invitational held
Female golfer swinging on the green.

Bonnie hosts the inaugural Dystonia Golf Invitational at the Century Country Club in Westchester, New York. The Hedi Kravis Ruger Memorial Golf Invitational will become one of the most successful fundraisers in dystonia research, raising $1 million annually.

Advocacy / Awareness icon
Advocacy / Awareness
1995
The Bachmann-Strauss Dystonia and Parkinson Foundation launched
Icon for "The Bachmann Strauss Dystonia & Parkinson's Foundation, Inc."

Bonnie establishes The Bachmann-Strauss Dystonia and Parkinson Foundation with her father, Louis Bachmann, convinced she can make an even bigger impact on research and public awareness of dystonia.

The Foundation will go on to fund more than 235 research grants to leading dystonia and Parkinson's researchers around the globe, as well as found four Centers of Excellence for comprehensive patient care.

View the full article

Advocacy / Awareness icon
Advocacy / Awareness

"We try to raise public awareness and raise funds for research. There is no known cause and no cure yet, so there is a lot of work to be done."

Bonnie Strauss, Founder, The Bachmann-Strauss Dystonia & Parkinson Foundation
1997
First dystonia-implicated gene, DYT-1, identified
Blue graphic of genes.

Partially supported by a grant from Bachmann-Strauss, a team led by Xandra Breakefield, PhD, identifies and clones DYT-1, the first dystonia-implicated gene, opening a floodgate of research progress.

Bachmann-Strauss support will play an instrumental role in the discovery of several additional dystonia-implicated genes, including TUBB-4 GNAL and AN03.

Scientific Achievements icon
Scientific Achievements
First Bachmann-Strauss Patient Symposium held
Poster for a symposium on practical living with Parkinson's.

Bachmann-Strauss' first Patient Symposium, a lecture about dystonia and Parkinson's disease, is held and soon develops into a day-long event providing comprehensive support to patients and caregivers. In 2006, the symposium will expand to two days, establishing a second day dedicated to a DBS reunion for patients who've undergone the surgery and for those considering it.

Patient Care icon
Patient Care
2001
International group of doctors and scientists gather for Think Tank on dystonia and Parkinson’s.
Group photo of individuals at a conference in 2001.

Bachmann-Strauss holds its first Think Tank on dystonia and Parkinson's disease. This international group of neurologists, geneticists and pharmacologists meets annually in New York City from 2001 to 2014 to discuss current issues in the field of dystonia and Parkinson's disease research, becoming a critical input for the Bachmann-Strauss scientific advisory board in determining next steps in future research.

Forging New Collaborations icon
Forging New Collaborations
2006
Deep Brain Stimulation for DYT-1 dystonia study funded
Doctor looking at brain scans for deep brain stimulation.

Bachmann-Strauss funds study of low-frequency Deep Brain Stimulation (DBS) for treatment of primary DYT-1 dystonia. The results of this work, published three years later, note significant improvement in motor function among patients treated with lower stimulation frequencies; they also benefit from longer battery life.

Scientific Achievements icon
Scientific Achievements
2008
Pre-clinical testing paradigm benefits dystonia drug development
Caucasian female researcher in the lab.

Leveraging previous advances in non-human models, Bachmann-Strauss establishes a pre-clinical testing paradigm benefitting future dystonia drug development.

Scientific Achievements icon
Scientific Achievements
“Jake’s Ride,” a growing community fundraiser
Logo for the Wall Street Journal.

Working with the Bachmann-Strauss Foundation, 10-year-old Jake Silverman, who is living with dystonia, and his family create a bike ride to raise awareness and funds for dystonia research. "Jake's Ride" quickly grows into one of the field's most important community fundraisers. By 2014, it crosses the $2-million mark in fundraising and enables support of 21 research grants and four movement disorder fellowships.

View the full article

Advocacy / Awareness icon
Advocacy / Awareness
2009
First Bachman-Strauss Center of Excellence is founded
Group of 12 researchers in white coats posing for a picture in a lab.

To address the complex problems facing dystonia patients, Bachmann-Strauss founds its first Bachmann-Strauss Center of Excellence at Beth Israel Mount Sinai Medical Center Department of Neurology, focusing on comprehensive care for people living with dystonia. By 2013, three more centers are established, each incorporating the relationship between dystonia and Parkinson's disease.

Patient Care icon
Patient Care
2011
Bachmann-Strauss funds MJFF research efforts in disease understanding
Hands with purple gloves on in lab holding research tool.

With funding from Bachmann-Strauss, MJFF awards a research grant resulting in understanding mutations in the Park 9 gene and their link to dystonia and Parkinson's symptoms. The Bachmann-Strauss Foundation's funding to The Michael J. Fox Foundation by 2014 will total more than $500,000 enabling instrumental progress in the study of dystonia, dyskinesia and Parkinson's disease.

Scientific Achievements icon
Scientific Achievements
Researchers discover role of protein in Parkinson’s progression
Logo for Science Daily Website.

With funding from Bachmann-Strauss, researchers discover a protein that plays a role in how the previously discovered parkin genetic mutation leads to cell death and Parkinson's progression. The study observes that the mutation blocks parkin's ability to degrade proteins, leading to accumulation of the protein PARIS, which limits production of the protective protein PGC-1alpha. Without that defense, brain cells are susceptible to disease.

View the full article

Scientific Achievements icon
Scientific Achievements
2012
Mayor Bloomberg declares “Dystonia Call for Action Day”
Logo for Huffington Post's New York Impact news section.

Then-New York City Mayor Michael Bloomberg, a former Board member and longtime supporter of the Bachmann-Strauss Foundation, declares Monday, June 18, 2012, "Dystonia Call for Action Day" at the Foundation's 20th anniversary Golf Invitational. Bachmann-Strauss has drawn the attention and support of celebrities and notable figures nationwide.

View the full article

Scientific Achievements icon
Scientific Achievements
Bachmann-Strauss commits funding to regenerative medicine
Hands with purple gloves on in lab holding research tool.

Bachmann-Strauss' commitment to funding regenerative medicine for the benefit of people living with dystonia results in two interrelated grants to researchers working with induced pluripotent stem cells (iPSC). The researchers are tasked with collaborating on the development of scientific infrastructure to collect and analyze iPSC for dystonia, and the generation of specific cell lines to study different genetic forms of the disease.

Forging New Collaborations icon
Forging New Collaborations
2013
New genes linked to primary dystonia identified

With funding partly from Bachmann-Strauss, researchers identify additional genes linked to causing primary dystonia, including mutations on the GNAL, TUBB4 and AN03 genes.

Scientific Achievements icon
Scientific Achievements
Three new Centers of Excellence named
Two doctors performing deep brain stimulation.

Bachmann-Strauss establishes three more Centers of Excellence at The University of Alabama at Birmingham, The University of California, San Francisco, and The University of Florida. These Centers focus on care for both dystonia and Parkinson's disease.

Forging New Collaborations icon
Forging New Collaborations
Bachmann-Strauss joins Fox Trial Finder as Community Partner
Fox Trial Finder Logo

Bachmann-Strauss becomes one of 16 Clinical Trial Recruitment Community Partners with Fox Trial Finder, a coalition of high-profile research organizations around the world dedicated to raising awareness about the need for clinical trial participants, educating about what it means to participate in research and providing actionable steps that anyone can take to get involved in Parkinson's research.

Forging New Collaborations icon
Forging New Collaborations
“Disease and the Public Eye,” a New York Times opinion piece published
Ali London

Attorney Allison London, a Bachmann-Strauss Board member, Young Leadership Council chair and prominent dystonia advocate, publishes "Disease and the Public Eye," an opinion piece, in the New York Times. "Michael J. Fox has done as much for dystonia awareness as anyone in the history of the disease," she writes in part.

View the full article

 

Advocacy / Awareness icon
Advocacy / Awareness
2014
Centers of Excellence collaborate on DBS research
Three Caucasian female doctors looking at a laptop.

On the front lines of patient care, the Centers of Excellence combine the clinical experience with opportunities to advance research by collaborating on a $300,000 investigation into the responsiveness to DBS among patients.

Forging New Collaborations icon
Forging New Collaborations
Marathon team crosses $1.5 million in fundraising
Three Caucasian males running a marathon.

In its ninth year, thanks to its committed runners and supporters, Bachmann-Strauss' New York City Marathon team crosses $1.5 million in fundraising.

Advocacy / Awareness icon
Advocacy / Awareness
2015
Bachmann-Strauss forms research alliance with The Michael J. Fox Foundation
Michael J. Fox with Bonnie and Tom Strauss.

Bachmann-Strauss forms a new collaborative research alliance with The Michael J. Fox Foundation to raise awareness and deepen investment in advancing dystonia and Parkinson's disease research. The alliance, taking effect January 2015, refocuses Bachmann-Strauss funding in support of a newly established annual prize, the Bachmann-Strauss Prize for Excellence in Dystonia Research.

Forging New Collaborations icon
Forging New Collaborations

"Partnering with BSDPF allows us to deepen our work together in support of high-impact scientific findings that will benefit both dystonia and Parkinson's patients."

Todd Sherer
PhD
CEO of The Michael J. Fox Foundation
Inaugural Bachmann-Strauss Prize for Excellence in Dystonia Research awarded

On May 13, 2015, the inaugural Bachmann-Strauss Prize for Excellence in Dystonia Research was awarded to Xandra O. Breakefield, PhD, professor of neurology at Harvard Medical School and geneticist at Massachusetts General Hospital, for her groundbreaking discoveries in the field of dystonia genetics. The gala event, held in New York City, also celebrated the achievements of the Bachmann-Strauss Dystonia and Parkinson Foundation and its founder, Bonnie Strauss. The event raised $1.7 million to support dystonia and Parkinson's research

2016
Co-awardees of second Bachmann-Strauss Prize chosen

The second Bachmann-Strauss Prize for Excellence in Dystonia Research was awarded to Susan Bressman, MD, chair of the Department of Neurology at Mount Sinai Beth Israel, and Laurie Ozelius, PhD, associate neuroscientist and associate professor of neurology at Massachusetts General Hospital and Harvard Medical School. The researchers, who have collaborated for 30 years, were chosen for their work in dystonia genetics. The prizes were conferred in New York City on November 12, 2016.

Advocacy / Awareness icon
Advocacy / Awareness
1979
Bonnie Strauss diagnosed with dystonia
Head shot of board member Bonnie Strauss.

Bonnie Strauss begins experiencing neck spasms that force her to seek medical attention. Bonnie visits all types of doctors, from psychiatrists to chiropractors, seeking answers. In 1984, five years after onset of symptoms, Bonnie is connected with a neurologist in New York City, who properly diagnoses her with spasmodic torticollis, a form of dystonia characterized by involuntary contractions of the muscles in the neck. Bonnie comes to strongly believe there is a link between dystonia and Parkinson's, having seen her mother and grandmother both live with Parkinson's disease.

Advocacy / Awareness icon
Advocacy / Awareness
1993
Inaugural Dystonia Golf Invitational held
Female golfer swinging on the green.

Bonnie hosts the inaugural Dystonia Golf Invitational at the Century Country Club in Westchester, New York. The Hedi Kravis Ruger Memorial Golf Invitational will become one of the most successful fundraisers in dystonia research, raising $1 million annually.

Advocacy / Awareness icon
Advocacy / Awareness
1995
The Bachmann-Strauss Dystonia and Parkinson Foundation launched
Icon for "The Bachmann Strauss Dystonia & Parkinson's Foundation, Inc."

Bonnie establishes The Bachmann-Strauss Dystonia and Parkinson Foundation with her father, Louis Bachmann, convinced she can make an even bigger impact on research and public awareness of dystonia.

The Foundation will go on to fund more than 235 research grants to leading dystonia and Parkinson's researchers around the globe, as well as found four Centers of Excellence for comprehensive patient care.

View the full article

Advocacy / Awareness icon
Advocacy / Awareness

"We try to raise public awareness and raise funds for research. There is no known cause and no cure yet, so there is a lot of work to be done."

Bonnie Strauss, Founder, The Bachmann-Strauss Dystonia & Parkinson Foundation
1997
First dystonia-implicated gene, DYT-1, identified
Blue graphic of genes.

Partially supported by a grant from Bachmann-Strauss, a team led by Xandra Breakefield, PhD, identifies and clones DYT-1, the first dystonia-implicated gene, opening a floodgate of research progress.

Bachmann-Strauss support will play an instrumental role in the discovery of several additional dystonia-implicated genes, including TUBB-4 GNAL and AN03.

Scientific Achievements icon
Scientific Achievements
First Bachmann-Strauss Patient Symposium held
Poster for a symposium on practical living with Parkinson's.

Bachmann-Strauss' first Patient Symposium, a lecture about dystonia and Parkinson's disease, is held and soon develops into a day-long event providing comprehensive support to patients and caregivers. In 2006, the symposium will expand to two days, establishing a second day dedicated to a DBS reunion for patients who've undergone the surgery and for those considering it.

Patient Care icon
Patient Care
2001
International group of doctors and scientists gather for Think Tank on dystonia and Parkinson’s.
Group photo of individuals at a conference in 2001.

Bachmann-Strauss holds its first Think Tank on dystonia and Parkinson's disease. This international group of neurologists, geneticists and pharmacologists meets annually in New York City from 2001 to 2014 to discuss current issues in the field of dystonia and Parkinson's disease research, becoming a critical input for the Bachmann-Strauss scientific advisory board in determining next steps in future research.

Forging New Collaborations icon
Forging New Collaborations
2006
Deep Brain Stimulation for DYT-1 dystonia study funded
Doctor looking at brain scans for deep brain stimulation.

Bachmann-Strauss funds study of low-frequency Deep Brain Stimulation (DBS) for treatment of primary DYT-1 dystonia. The results of this work, published three years later, note significant improvement in motor function among patients treated with lower stimulation frequencies; they also benefit from longer battery life.

Scientific Achievements icon
Scientific Achievements
2008
Pre-clinical testing paradigm benefits dystonia drug development
Caucasian female researcher in the lab.

Leveraging previous advances in non-human models, Bachmann-Strauss establishes a pre-clinical testing paradigm benefitting future dystonia drug development.

Scientific Achievements icon
Scientific Achievements
“Jake’s Ride,” a growing community fundraiser
Logo for the Wall Street Journal.

Working with the Bachmann-Strauss Foundation, 10-year-old Jake Silverman, who is living with dystonia, and his family create a bike ride to raise awareness and funds for dystonia research. "Jake's Ride" quickly grows into one of the field's most important community fundraisers. By 2014, it crosses the $2-million mark in fundraising and enables support of 21 research grants and four movement disorder fellowships.

View the full article

Advocacy / Awareness icon
Advocacy / Awareness
2009
First Bachman-Strauss Center of Excellence is founded
Group of 12 researchers in white coats posing for a picture in a lab.

To address the complex problems facing dystonia patients, Bachmann-Strauss founds its first Bachmann-Strauss Center of Excellence at Beth Israel Mount Sinai Medical Center Department of Neurology, focusing on comprehensive care for people living with dystonia. By 2013, three more centers are established, each incorporating the relationship between dystonia and Parkinson's disease.

Patient Care icon
Patient Care
2011
Bachmann-Strauss funds MJFF research efforts in disease understanding
Hands with purple gloves on in lab holding research tool.

With funding from Bachmann-Strauss, MJFF awards a research grant resulting in understanding mutations in the Park 9 gene and their link to dystonia and Parkinson's symptoms. The Bachmann-Strauss Foundation's funding to The Michael J. Fox Foundation by 2014 will total more than $500,000 enabling instrumental progress in the study of dystonia, dyskinesia and Parkinson's disease.

Scientific Achievements icon
Scientific Achievements
Researchers discover role of protein in Parkinson’s progression
Logo for Science Daily Website.

With funding from Bachmann-Strauss, researchers discover a protein that plays a role in how the previously discovered parkin genetic mutation leads to cell death and Parkinson's progression. The study observes that the mutation blocks parkin's ability to degrade proteins, leading to accumulation of the protein PARIS, which limits production of the protective protein PGC-1alpha. Without that defense, brain cells are susceptible to disease.

View the full article

Scientific Achievements icon
Scientific Achievements
2012
Mayor Bloomberg declares “Dystonia Call for Action Day”
Logo for Huffington Post's New York Impact news section.

Then-New York City Mayor Michael Bloomberg, a former Board member and longtime supporter of the Bachmann-Strauss Foundation, declares Monday, June 18, 2012, "Dystonia Call for Action Day" at the Foundation's 20th anniversary Golf Invitational. Bachmann-Strauss has drawn the attention and support of celebrities and notable figures nationwide.

View the full article

Scientific Achievements icon
Scientific Achievements
Bachmann-Strauss commits funding to regenerative medicine
Hands with purple gloves on in lab holding research tool.

Bachmann-Strauss' commitment to funding regenerative medicine for the benefit of people living with dystonia results in two interrelated grants to researchers working with induced pluripotent stem cells (iPSC). The researchers are tasked with collaborating on the development of scientific infrastructure to collect and analyze iPSC for dystonia, and the generation of specific cell lines to study different genetic forms of the disease.

Forging New Collaborations icon
Forging New Collaborations
2013
New genes linked to primary dystonia identified

With funding partly from Bachmann-Strauss, researchers identify additional genes linked to causing primary dystonia, including mutations on the GNAL, TUBB4 and AN03 genes.

Scientific Achievements icon
Scientific Achievements
Three new Centers of Excellence named
Two doctors performing deep brain stimulation.

Bachmann-Strauss establishes three more Centers of Excellence at The University of Alabama at Birmingham, The University of California, San Francisco, and The University of Florida. These Centers focus on care for both dystonia and Parkinson's disease.

Forging New Collaborations icon
Forging New Collaborations
Bachmann-Strauss joins Fox Trial Finder as Community Partner
Fox Trial Finder Logo

Bachmann-Strauss becomes one of 16 Clinical Trial Recruitment Community Partners with Fox Trial Finder, a coalition of high-profile research organizations around the world dedicated to raising awareness about the need for clinical trial participants, educating about what it means to participate in research and providing actionable steps that anyone can take to get involved in Parkinson's research.

Forging New Collaborations icon
Forging New Collaborations
“Disease and the Public Eye,” a New York Times opinion piece published
Ali London

Attorney Allison London, a Bachmann-Strauss Board member, Young Leadership Council chair and prominent dystonia advocate, publishes "Disease and the Public Eye," an opinion piece, in the New York Times. "Michael J. Fox has done as much for dystonia awareness as anyone in the history of the disease," she writes in part.

View the full article

 

Advocacy / Awareness icon
Advocacy / Awareness
2014
Centers of Excellence collaborate on DBS research
Three Caucasian female doctors looking at a laptop.

On the front lines of patient care, the Centers of Excellence combine the clinical experience with opportunities to advance research by collaborating on a $300,000 investigation into the responsiveness to DBS among patients.

Forging New Collaborations icon
Forging New Collaborations
Marathon team crosses $1.5 million in fundraising
Three Caucasian males running a marathon.

In its ninth year, thanks to its committed runners and supporters, Bachmann-Strauss' New York City Marathon team crosses $1.5 million in fundraising.

Advocacy / Awareness icon
Advocacy / Awareness
2015
Bachmann-Strauss forms research alliance with The Michael J. Fox Foundation
Michael J. Fox with Bonnie and Tom Strauss.

Bachmann-Strauss forms a new collaborative research alliance with The Michael J. Fox Foundation to raise awareness and deepen investment in advancing dystonia and Parkinson's disease research. The alliance, taking effect January 2015, refocuses Bachmann-Strauss funding in support of a newly established annual prize, the Bachmann-Strauss Prize for Excellence in Dystonia Research.

Forging New Collaborations icon
Forging New Collaborations

"Partnering with BSDPF allows us to deepen our work together in support of high-impact scientific findings that will benefit both dystonia and Parkinson's patients."

Todd Sherer
PhD
CEO of The Michael J. Fox Foundation
Inaugural Bachmann-Strauss Prize for Excellence in Dystonia Research awarded

On May 13, 2015, the inaugural Bachmann-Strauss Prize for Excellence in Dystonia Research was awarded to Xandra O. Breakefield, PhD, professor of neurology at Harvard Medical School and geneticist at Massachusetts General Hospital, for her groundbreaking discoveries in the field of dystonia genetics. The gala event, held in New York City, also celebrated the achievements of the Bachmann-Strauss Dystonia and Parkinson Foundation and its founder, Bonnie Strauss. The event raised $1.7 million to support dystonia and Parkinson's research

2016
Co-awardees of second Bachmann-Strauss Prize chosen

The second Bachmann-Strauss Prize for Excellence in Dystonia Research was awarded to Susan Bressman, MD, chair of the Department of Neurology at Mount Sinai Beth Israel, and Laurie Ozelius, PhD, associate neuroscientist and associate professor of neurology at Massachusetts General Hospital and Harvard Medical School. The researchers, who have collaborated for 30 years, were chosen for their work in dystonia genetics. The prizes were conferred in New York City on November 12, 2016.

Advocacy / Awareness icon
Advocacy / Awareness
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.